Presentation held at:
Discovery Chemistry Congress
March 2012, Munich, Germany
ABSTRACT
There is an obvious synergy between experimental fragment based drug design (FBDD) and computational fragment based de novo design (FBDND). The underlying methodology of FBDND will be discussed as will its successful application to antimalarial lead discovery.